Consumer Discretionary • Catalog/Specialty Distribution
$7.58 ▼ -0.17
(-2.19%)
MKT CAP: $379.0M • VOL: 137.5K
52W L $7 52W H $20
QVCG // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $8.29B | $9.00B | $9.45B |
| YoY Revenue Growth % | -7.8% | -4.8% | — |
| Gross Profit | $2.79B | $3.09B | — |
| Gross Margin % | 33.6% | 34.4% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$2.02B | -$770.0M | $645.0M |
| Operating Margin % | -24.3% | -8.6% | 6.8% |
| Net Income (GAAP) | -$2.17B | -$1.07B | $159.0M |
| EBITDA (Normalized) | — | — | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $419.0M | $535.0M | $1.09B |
| Capital Expenditures (CapEx) | — | — | — |
| Free Cash Flow (FCF) | $419.0M | $535.0M | $1.09B |
| FCF Margin % | 5.1% | 5.9% | 11.6% |
| Return on Invested Capital (ROIC %) | -45.0% | -9.6% | — |
| Cash & Short-Term Equivalents | $1.50B | $297.0M | — |
| Total Debt (Short + Long Term) | $1.0M | $3.31B | — |
| Total Stockholders' Equity | $1.20B | $3.29B | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR QVCG.